Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Mar 1 2023

Full Issue

FDA Cracking Down On Illegal Import Of Xylazine Amid Spike In Overdoses

The action allows for the detainment of shipments of the veterinary tranquilizer and the ingredients used to make it, CBS News reported. Xylazine, also known as "tranq" or "zombie drug" because it causes “patches of dead and rotting tissue," has exacerbated the nation's opioid crisis and has been found in samples from 32 states, The Washington Post says.

CBS News: FDA Acts To Restrict Illicit Import Of Xylazine, Animal Tranquilizer Linked To Overdose Deaths

The U.S. Food and Drug Administration announced on Tuesday that it was taking action to restrict unlawful importing of the veterinary drug xylazine, which has been "increasingly found" in the nation's illicit drug supply. (Breen, 2/28)

The Washington Post: FDA To Restrict Imports Of An Animal Sedative, Xylazine, Tied To Overdoses 

The drug, known as “tranq” on the street, has alarmed public health experts, law enforcement officers and lawmakers already struggling to control an opioid crisis that is killing thousands each month. In recent years, the impact of xylazine has been particularly acute in Philadelphia, where the drug has been discovered in an overwhelming number of street opioid samples and as of 2019, in 31 percent of all victims of unintentional fatal overdoses in which fentanyl or heroin were detected. (Ovalle, 2/28)

Vice News: The Feds Are Cracking Down On Tranq Dope

Xylazine is typically sold as a liquid when used for veterinary purposes. However, as VICE News reported last March, hundreds of online vendors are selling powder forms of xylazine. One China-based seller told VICE News that xylazine had become a “hot” product among Americans in 2021. A report from the Drug Enforcement Administration from October found that a kilogram of xylazine powder can be bought from Chinese suppliers from $6-$20 per kilogram. “At this low price, its use as an adulterant may increase the profit for illicit drug traffickers, as its psychoactive effects allows them to reduce the amount of fentanyl or heroin used in a mixture,” the report said. (Krishnan, 2/28)

More on the scourge of xylazine —

WTOP: ‘Zombie Drug’ Challenging Response To Maryland Opioid Crisis 

The opioid epidemic in Maryland has entered a new and uncertain phase. Xylazine — also called “tranq” and “zombie drug” — is showing up more and more in the illicit drug supply across the state. ... The drug’s telltale signs are gruesome wounds near the injection sight. “We’re talking about pretty big wounds here — exposing both bone and actual muscles, tendons — very, very significant deep wounds,” said Dr. Malik Burnett, the director of the Center for Harm Reduction Services at the Maryland Department of Health. “Very much in the framework of amputation level.” (Garrett, 3/1)

KGET: Newest Killer On The Street: Xylazine, An Animal Tranquilizer That Doesn't Respond To Narcan

There’s a dangerous new drug out there that’s been devastating U.S. cities for the past year and it does not respond to the lifesaving anti-opioid drug Narcan. ... The lack of awareness and testing for Xylazine could mean its real impact has been underreported. Many county coroner’s offices do not test for it. (Price, 2/28)

In other news about the opioid crisis —

AP: West Virginia Senate Enhances Drug Penalties To Felony 

West Virginia’s Senate passed a bill Tuesday that would make it a felony to possess fentanyl and some other illegal drugs in the opioid-ravaged state. The bill passed on a 32-1 vote and now goes before the House of Delegates. The regular session ends March 11. (Raby, 2/28)

CBS News: Fentanyl In Alaska: How The Synthetic Opioid Is Affecting The State

An influx of fentanyl into Alaska in the last two years has vexed law enforcement, overwhelmed health systems and deeply affected struggling Native communities. In 2020 and 2021, the synthetic opioid was a major contributor in a spike in overdoses – the nation's largest, according to Alaska's public health department. In 2021, overdose deaths jumped by 74% in one year, with fentanyl deaths spiking by 150%, the report said. (Tabachnick, 3/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF